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Abstract
Arginine methylation broadly occurs in histones and has been linked to transcriptional regulation, cell cycle regulation and
DNA repair. While numerous proteins (histone code effectors) that specifically recognize or read the methylated lysine
residues in core histones have been identified, little is known for effectors specific for methylated arginines in histones. In
this study, we attempted to identify effector(s) recognizing asymmetrically methylated R17 and R26 in H3, which are
catalyzed by CARM1/PRMT4, through an unbiased biochemical approach. Although we have yet to identify such effector
using this approach, we find that these modifications function cooperatively with histone acetylation to inhibit the binding
of the nucleosome remodeling and deacetylase complex (NuRD) and TIF1 family corepressors to H3 tail in vitro. In support
of this finding, we show that overexpression of CARM1 in 293 T cells leads to reduced association of NuRD with chromatin,
whereas knockdown of CARM1 in HeLa cells leads to increased association of NuRD with chromatin and decreased level of
histone acetylation. Furthermore, in the Carm12/2 MEF cells there is an increased association of NuRD and TIF1b with
chromatin and a global decrease in histone acetylation. By chromatin immunoprecipitation assay, we show that
overexpression of CARM1 results in reduced association of NuRD complex and TIF1b with an episomal reporter and that
CARM1 is required in MEF cells for LPS-induced dissociation of NuRD from a NF-kb target gene. Taking together, our study
provides evidence for a role of CARM1-mediated arginine methylation in regulation of histone acetylation and transcription:
facilitating transcription by discharging corepressors from chromatin.
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Introduction
Accumulating evidence indicates that histone methylation plays
important regulatory roles in all DNA templated biological
processes including transcription, DNA replication and repair
[1–3]. Multiple lysine and arginine residues in core histones can be
methylated. Given their chemical nature, lysine residues can be
mono-, di- and tri-methylated, whereas arginine can be mono-,
asymmetrically and symmetrically di-methylated (me2a and me2s).
The availability of multiple lysine and arginine residues for
methylation, in combination with different degrees of methylation,
endows histone methylation to encode wealthy information and
underscores the complexity of methylation regulation [1,4].
As methyl group is relatively small in size and does not
neutralize positive charge in lysine and arginine, methylation is
believed to exert regulatory functions in chromatin primarily as
docking sites for effectors that recognize and engage physiological
functions of the specific methylation [5–7]. Since the initial
identification of bromodomain-containing proteins as acetylated
lysine and HP1 proteins as methylated H3K9 binding proteins [8–
10], an increasingly large number of effectors have been reported
for various methylated lysine residues in core histones [5,11–13].
However, despite broad existence of arginine methylation in
histones, upon to now TDRD3 and Dnmt3a are the only proteins
reported to bind methylated arginines in histones [14,15]. TDRD3
was shown to bind both H3R17me2a and H4R3me2a peptides
after screening a large panel of known and potential modified
histone binding structural motifs [15]. This result suggests that the
effectors for methylated arginines may either use different binding
motif(s) or are less abundant than effectors for methylated lysines.
On the other hand, H3R2 methylation has been shown to impede
the binding of effectors to methylated H3K4 [16], raising the
possibility that arginine methylation may impede rather than
attract binding of effector proteins.
CARM1/PRMT4 functions as a transcriptional coactivator for
various transcriptional factors including nuclear receptors and NF-
kb [3,17–19]. CARM1 is a type I arginine methyltransferase that
catalyzes mono- and asymmetrical dimethylation on R17 and R26
sites in histone H3 and non-histone proteins including CBP/p300,
SRC3 and RNA pol II [20–24]. Methylation of these non-histone
proteins has been linked to, and thus may in part account for,
CARM1 coactivator function. Nevertheless, an elegant in vitro
study using reconstituted chromatin substrates demonstrated that
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p53 depends on arginine methylation on histone H3 [25]. In the
same study, CARM1 was shown to stimulate transcription in a step
subsequent to p300-mediated histone acetylation. This sequential
working model is consistent with a previous study showing that
CBP-catalyzed histone acetylation in the PS2 promoter occurs
prior to CARM1-mediated H3R17 methylation during estrodial
induced activation of PS2 gene [26]. These studies together
indicate that CARM1-mediated histone methylation facilitates
transcription in the context of histone acetylation. However, how
methylation of H3R17 and H3R26 facilitates transcriptional
activation in the context of histone acetylation is not known.
In this study, we provide evidence that CARM1-mediated
H3R17me2a and H3R26me2a function cooperatively with
histone acetylation to inhibit the binding of corepressors and
protect chromatin from deacetylation. Thus, our study reveals
a novel function for CARM1-mediated arginine methylation:
facilitating transcription by discharging corepressors from chro-
matin.
Results
Asymmetrical Dimethylation on Either R17 or Both R17
and R26 does not Appear to Significantly Influence the
Binding of Nuclear Proteins to H3 Tail
To investigate how the CARM1-catalyzed H3R17me2a and
H3R26me2a stimulate transcription in chromatin, we attempted
to isolate and identify potential effector(s) that binds specifically
H3R17me2a and/or H3R26me2a. We first synthesized biotiny-
lated peptides corresponding to the amino acid sequence 9–31 of
H3 N-terminal tail containing either unmodified [H3(9–31)],
R17me2a [H3mR17 peptide] or R17me2a + R26me2a
[H3mR17/26] peptides. Approximately 5 mg of each peptide
was immobilized to streptavidin agarose beads and incubated with
HeLa nuclear extracts under relatively mild condition (see
Experimental Procedure). After extensive washing, the proteins
that bound to immobilized peptides were eluted, resolved by SDS-
PAGE and visualized by silver staining. A representative result in
Fig. 1A shows that many proteins were retained by immobilized
H3(9–31) peptides but not the control beads. Somewhat disap-
pointingly, we did not observe any protein band that was unique to
either H3mR17 or H3mR17/26 peptides. Similar results were
obtained in multiple efforts under different incubation and
washing conditions including salt concentrations ranging from
100 mM to 350 mM and NP40 from 0.05% to 0.5%. These
results were very different from what we and others observed for
H3 peptides with K4me2/3 or K9me2/3 [27–30]. K4 methyla-
tion substantially changes the profile of H3 binding proteins, on
one hand impeding the binding of NuRD complex and on the
other hand enhancing the binding of many effector proteins
including CHD1 [31,32], TFIID [33], Ing2 [34,35], nardilysin
[36] and PHF8 [37,38]. We thus concluded that asymmetrical
dimethylation on either R17 or both R17 and R26 did not appear
to significantly influence the binding of nuclear proteins to the
amino acids 9–31 of H3 tail.
Asymmetrical Dimethylation on Both R17 and R26 Acts
Cooperatively with Acetylation to Inhibit the Binding of
Corepressors NuRD and TIF1 Family Proteins to H3 Tail
Given that the CARM1-catalyzed H3R17me2a and
H3R26me2a are likely to facilitate transcription in a step sub-
sequent to histone acetylation [25,26], R17/26me2a may work
together with acetylation as combinatorial code(s) to specify
binding of effector(s). To test this hypothesis, we synthesized four
new H3 peptides from amino acid 1 to 31. These peptides contain
either unmodified (H3 peptide), R17me2a alone (H3mR17
pepetide), acetylation on four (K9, K14, K18 and K23) (AcH3
peptide) frequently acetylated sites, and acetylation plus R17/
R26me2a (Ac/mR-H3 peptide)) (Fig. 1B top panel). These
peptides were used to purify binding proteins from HeLa nuclear
extracts as above. The results in Fig. 1B (see light exposure on
right panel) showed that R17me2a modification alone again did
not change the binding profile of HeLa nuclear proteins to H3
peptide. Significantly, while much less proteins bound to acH3
peptide in comparison to the H3 peptide, even less proteins bound
to the Ac/mR H3 peptide. We subjected the major protein bands
that bound to AcH3 but not to Ac/mR-H3 peptide to mass
spectrometry analysis and identified them as TIF1A, TIF1B and
metastasis-associated protein 1 and 2(MTA1/2), respectively.
TIF1a/TRIM24 and TIF1b/KAP1/TRIM28 are related
transcriptional cofactors belonging to the tripartite motif family
proteins [39]. TIF1a has been implicated in both transcriptional
activation and repression. TIF1b is the corepressor for the
Krupple family and other transcription factors and has been
shown to interact with HDACs, SETDB1 and HP1 [40,41].
MTA1 and MTA2 are subunits of the NuRD complexes that
contain both ATP-dependent chromatin remodeling activity and
histone deacetylase activity [42,43]. In addition to the MTA family
proteins (MTA1, MTA2 and MTA3), the NuRD complex
contains either a CHD3 or CHD4 helicase subunit, HDAC1/2,
RbAP46/48 and several other proteins. Current studies indicate
that NuRD is one of the most abundant HDAC complex in HeLa
cells and has a broad transcriptional regulatory function. To
substantiate our mass spectrometry results described above, we
performed pulldown as above and subjected the peptide pulldown
materials to Western blot analysis using various antibodies against
the components of NuRD complex and TIF1b. The results in
Fig. 1C revealed that mR17me2a alone did not affect the binding
of MTA1 and TIF1b to H3 peptide. However, less MTA1 and
TIF1bbound to the AcH3 peptide than to the H3 peptide. In
agreement with the silver staining data in Fig. 1B, Western blot
analysis demonstrated that even less MTA1 and TIF1b bound to
the Ac/mRH3 peptide. (Fig. 1C). We also analyzed the binding
profile of HDAC1/2 and the results in Fig. 1C showed that
HDAC1/2 exhibited the same binding profile as MTA1, in
agreement with HDAC1/2 being subunits of the NuRD complex.
Using in vitro synthesized,
35S-methionine labeled MTA1 and
TIF1A, we further showed that these proteins bound poorly to the
AcH3 peptide and even worse to the Ac/mR-H3 peptide (Fig. 1D).
As NuRD and TIF1b are well established for their corepressor
function, these data reveal that H3R17 and H3R26 methylation
may function in conjunction with acetylation to impede binding of
corepressors to chromatin.
Overexpression of CARM1 in 293 T Cells Resulted in
Reduced Chromatin Association of NuRD and TIF1b
To test if the effect of H3R17/R26 methylation on binding of
corepressor proteins is physiological relevant, we first tested if
overexpression of CARM1 in cells would lead to reduced
chromatin association of NuRD complex. Toward this end, we
established a doxycycline (Dox) inducible CARM1 expression
293 T (293T-CARM1) cell line using 293 T Flp-In T-Rex cells.
Pilot experiments showed that induction of Flag-CARM expres-
sion was detectable 4 h after addition of Dox, and increased
gradually and reached maximal levels around 24 h (data not
shown). To balance the need for induction of Flag-CARM1 and
minimizing the potential secondary effect of Flag-CARM1 over-
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shown in Fig. 2A, addition of Dox for 12 h substantially induced
the expression of Flag-CARM1. Western blot analysis using
a CARM1-specific antibody showed that upon induction the total
level of CARM1 increased about 3–4 fold. We next established
conditions to fractionate 293T-CARM1 cells into cytosol, nuclear
and chromatin fractions (Fig. 2B). As markers for appropriate
cellular fractionation, actin was detected in both cytosol and
nuclear fractions, whereas H3 was detected only in chromatin. In
addition, the components of NuRD complex CHD3 and MTA1
were present in all three fractions, whereas nucleolin and CARM1
were present in nuclear and chromatin fractions.
With the establishment of conditions for cellular fractionation,
we prepared the chromatin fractions form the control 293 T and
293T-CARM1 cell lines treated with or without Dox for 12 h.
Subsequent Western blot analysis (Fig. 2C) revealed an increased
association of Flag-CARM1 with chromatin from 293T-CARM1
cells, in agreement with Flag-CARM1 being induced by Dox
treatment. Dox treatment also led to a small, but consistently
detectable, increase of H3R17me2a (,2 fold) in the 293T-
CARM1 but not the control 293 T cells. Due to lack of a good
antibody H3R26me2a, however we could not demonstrate
directly by Western blot analysis whether induced expression of
CARM1 also led to increased level of H3R26me2a. To our
satisfaction, we found that Dox treatment led to reduced
chromatin association of CHD3, MTA1, HDAC1 and TIF1b in
the 293T-CARM1 but not the control 293 T cells (Fig. 2C). As
a control, the association of nucleolin with chromatin was not
significantly affected. These results provide evidence that increased
expression of CARM1 can lead to increased H3R17 methylation
(possibly also H3R26 methylation) and reduced association of
NuRD complex and TIF1b with chromatin.
Knockdown of CARM1 in HeLa Cells Resulted in Increased
Chromatin Association of NuRD and Reduced Histone H3
and H4 Acetylation
To further test the effect of CARM1 on chromatin association
of NuRD, we next attempted loss of function experiments by
knockdown of CARM1 in HeLa cells using two different shRNAs.
HeLa cells were transfected with the control or shCARM1
plasmids and 48 h after transfection the cells were collected and
divided into two half, with one for preparation of whole cell
extracts and one for preparation of chromatin fractions. Sub-
sequent Western blot analysis of the resulting whole cell extracts
revealed that transfection of two different shCARM1 plasmids, but
not the control shRNA (against GFP), efficiently reduced the levels
of CARM1 in HeLa cells (Fig. 3A). Western blot analysis also
revealed that knockdown of CARM1 in HeLa cells did not affect
the protein levels of TIF1b, CHD3, CHD4, HDAC1 and
nucleolin (Fig. 3A). However, Western blot analysis of the
chromatin fractions revealed that knockdown of CARM1 resulted
in an increased association of TIF1b, CHD3, CHD4 and HDAC1
with chromatin (Fig. 3B). As a control, the association of nucleolin
with chromatin was not changed (Fig. 3B).
As NuRD is one of the most abundant histone deacetylase
complexes in HeLa cells, we tested whether increased chromatin
association of NuRD complex upon knockdown of CARM1 would
affect histone acetylation in chromatin. Significantly, we found
that knockdown of CARM1 indeed resulted in decreased levels of
acetylated H3 and H4 (Fig. 3B). The effect of knockdown of
CARM1 on histone acetylation was further confirmed by
immunofluorecent staining using antibodies against acetylated
H3 and H4 (Fig. 3C). Together these results indicate that
knockdown of CARM1 in HeLa cells results in increased
association of NuRD and TIF1b with chromatin and histone
hypoacetylation.
Chromatin from the Carm12/2 MEF Cells Shows
Increased Corepressor Association and Histone
Hypoacetylation
To further substantiate our finding that CARM1 regulates the
association of NuRD complex with chromatin and consequently
histone acetylation, we next made use of paired wild-type and
Carm12/2 MEF cells generated by Mark Bedford’s group [21].
We prepared the whole cell extracts and chromatin fractions from
these cell lines. First, we confirmed by Western blot analysis the
absence of CARM1 proteins in the whole cell extracts derived
from the Carm12/2 MEF cells (Fig. 4A). No obvious differences
in the levels of total proteins were observed for CHD3, CHD4,
MTA1, HDAC1 and nucleolin between the wild-type and
Carm12/2 MEFs. However, Western blot analysis of the
chromatin fractions revealed increased association of CHD3,
CHD4, MTA1 and HDAC1 with chromatin from the Carm12/2
MEF cells (Fig. 4B). As a control for specificity, no increased
association was observed for nucleolin. In agreement with the
shCARM1 results from HeLa cells, the chromatin prepared from
the Carm12/2 cells was found to contain hypoacetylated histones
H3 and H4 in comparison to the chromatin from the wild-type
MEF cells (Fig. 4B). This hypoacetylation phenotype was further
confirmed by analysis of the core histones prepared from both
wild-type and Carm12/2 MEF cells using acid extraction
method (Fig. 4C). Note that Western blot analysis confirmed
reduced level of H3R17me2a in the core histones derived from the
Carm12/2 cells (Fig. 4C).
Expression of CARM1 Dissociates NuRD and TIF1b from
Chromatin
The above results reveal that overexpression and knockdown or
knockout of CARM1 all grossly affect the association of NuRD
and TIF1b with chromatin and consequently histone acetylation.
Figure 1. H3R17me2a and H3R26me2a inhibit binding of NuRD and TIF1 family proteins to acetylated H3 tail peptide. (A) Purification
of HeLa nuclear proteins using immobilized control and H3 peptides containing either R17me2a (H3mR17) or R17me2a and R26me2a double
methylation (H3mR17/26). All peptides correspond to H3 N-terminal tail amino acids 9–29 and have three additional amino acids GGK plus a C-
terminal Biotin. The peptides were first immobilized to streptavidin agarose beads and then incubated with HeLa nuclear extracts. The proteins
retained by the control beads (2) or immobilized peptides were resolved by 10% SDS-PAGE and visualized by silver staining. (B) Purification of HeLa
nuclear proteins using H3 peptides containing either acetylation (AcH3) or both acetylation and R17/R26me2a (Ac/mR-H3). All peptides correspond
to H3 tail amino acids 1–29. The bound proteins were resolved by 10% SDS-PAGE and revealed by silver staining. The major bands that were present
in the lane of AcH3 but absent in the lane of Ac/mR-H3 were excised and identified by mass spectrometry analysis. The light exposure was shown for
proteins bound to H3 and H3 mR17 peptide. Note R17me2a alone did not appear to affect the binding of numerous proteins to H3 peptide. (C)
Western blot analysis confirmed the inhibitory effect of H3R17/26me2a on the binding of NuRD complex and TIF1b to acetylated H3 peptide. The
proteins bound to various immobilized peptides were analyzed by western blotting using antibodies as indicated. (D) In vitro synthesized MTA1 and
TIF1a bound poorly to Ac/mR-H3. MTA1 and TIF1a were synthesized and radiolabled with
35S-methionine using transcription and translation coupled
reaction (Promega) and subjected to pulldown assay using peptides as indicated. The binding of MTA1 and TIF1a was revealed by autoradiography.
doi:10.1371/journal.pone.0034692.g001
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chromatin association using a modified episomal reporter by
chromatin immunoprecipitation (ChIP) assay. This pREP7 based
episomal reporter (pREP7-MMTV-Luc) can replicate and main-
tain as minichromosomes in cells, because the vector contains an
Epstein-Barr virus replication origin (oriP) and EBNA gene
required for oriP based replication. As CARM1 is a coactivator
for androgen receptor (AR) [17], the initial thought was to test if
expression of CARM1 facilitates the dissociation of corepressors
NuRD and TIF1b from the reporter in the presence of AR. The
results in Fig. 5A showed that expression of CARM1 enhanced, as
expected, the hormone-dependent (+R1881) transcriptional acti-
vation from the pREP7-MMTV-Luc reporter by AR. However,
we also noticed that expression of CARM1 in the absence of
R1881 increased the levels of luciferase activity, suggesting that
expression of CARM1 alone may moderately activate transcrip-
tion. Indeed, we found that expression of CARM1 alone enhanced
the luciferase activity from the reporter in a dose-dependent
manner (Fig. 5B). This observation allowed us to test the effect of
overexpression of CARM1 alone on the association of corepressors
NuRD and TIF1b with chromatin, thus avoiding the complication
resulting from the action of various coactivators recruited by AR.
We therefore expressed the reporter with and without CARM1
and carried out chromatin immunoprecipitation assay to assess the
effect CARM1 expression on the association of NuRD and TIF1b
with chromatin. The representative semi-quantitative PCR results
in Fig. 5C showed that expression of CARM1 led to reduced
association of CHD3, MTA1 and TIF1b and increased association
of CARM1 and increased level of H3R17me2. The above results
were further verified by quantitative PCR analysis as shown in
Fig. 5D.
To test further a role for CARM1 in regulating the association
of NuRD corepressor complex with chromatin in a physiological
relevant condition, we next made use of Carm1+/+ and
Carm12/2 MEF cells. A previous study has identified a subset
of NF-kb target genes including MIP-2 and G-CSF whose
expression is induced by LPS in the Carm1+/+ but not in
Carm12/2 MEF cells [19]. These MEF cells were treated with or
Figure 2. Overexpression of CARM1 in 293 T cells reduced the association of NuRD complex and TIF1b with chromatin. (A)
Characterization of Dox inducible 293 T Flip-in CARM1 expression cell line. The 293T-CARM1 and control cells were treated with 0.5 mg/ml Dox for
12 h and the expression of induced expression of Flag-CARM1 was detected by Western blotting using anti-Flag antibody. The levels of total CARM1
were revealed by Western blotting using an anti-CARM1 antibody. (B) Establish the conditions to fractionate the 293T-CARM1 cells into cytosol,
nuclear and chromatin fractions. The fractionation was performed in duplicate. (C) Induced expression of CARM1 led to reduced chromatin
association of NuRD complex and TIF1b. The control and 293T-CARM1 cell lines were treated without or with Dox for 0.5 mg/ml 12 h and chromatin
fractions were prepared and analyzed for histone modifications and association of CARM1, components of NuRD complex, TIF1b and nucleolin as
indicated.
doi:10.1371/journal.pone.0034692.g002
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acetylation. (A) Efficient knockdown of CARM1 in HeLa cells using two shRNAs against CARM1 as revealed by Western blot analysis. The cells were
transfected with control or shRNAs against CARM1 for 3 days. The whole cell extracts were prepared and analyzed by Western blotting using
antibodies as indicated. Note knockdown of CARM1 did not affect the levels of other proteins tested. (B) Knockdown of CARM1 in HeLa cells resulted
in increased chromatin association of NuRD complex and TIF1b and histone hypoacetylation. Chromatin fractions were prepared from HeLa cells
treated with control or shRNAs against CARM1 for 3 days and analyzed by Western blotting using antibodies as indicated. (C) Transfection of HeLa
cells by shRNA against CARM1 resulted in reduced histone acetylation as revealed by immunofluorescent staining. HeLa cells were transfected with
shCARM1A as indicated and subjected to immunofluorescent staining 48 h after transfection. The shRNA transfected cells were GFP positive as the
shRNA vector expressed GFP. Note the GFP positive cells were low in acetylated H3 and H4 immunostaining.
doi:10.1371/journal.pone.0034692.g003
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collected for preparation of total RNAs. Quantitative RT-PCR
analysis confirmed that LPS-induced MIP-2 expression was
severely impaired (Fig. 6A), whereas the expression of another
NF-kb target gene G-CSF was less affected (Fig. 6B). Subsequent
ChIP analysis was then focused on the promoter of MIP-2 gene
and the results in Fig. 6C show that LPS treatment led to reduced
association of MTA2 and CHD4 with chromatin. However, ChIP
analysis revealed that LPS treatment did not result in reduced
association of MTA2 and CHD4 with chromatin (Fig. 6D). These
results provide further evidence that CARM1 regulates the
chromatin association of NuRD complex.
Discussion
Arginine methylation broadly occurs in histones and non-
histone proteins [3]. Lysine methylation on various sites of histones
plays diverse functions that have been linked to its ability to recruit
distinct binding or effector proteins. Indeed, numerous proteins
with chromo, PHD, WD40 or tudor domain have been identified
collectively as effectors for methylated H3K4, H3K9, H3K27,
H3K36 and H4K20 [5–7]. In contrast, TDRD3 is currently the
lonely effector identified for arginine-methylated histones from
a protein microarray [16]. This result suggests that the effectors for
methylated arginines may either use different binding motif(s) or
are less abundant than effectors for methylated lysines. In this
study, we employed an unbiased affinity purification approach to
identify from HeLa nuclear extracts the effectors for H3R17me2a
and H3R26me2a. This same approach has led us to the
identification of large numbers of H3K4me2- and H3K9me2-
binding proteins [30]. However, despite of our extensive efforts,
we have yet to identify a protein that binds specifically or
preferentially to H3R17me2a and/or H3R26me2a. Careful
comparison of protein band profiles of sliver staining gels did
not reveal any obvious protein band that was enriched by
H3R17me2a and/or H3R26me2a peptides but not by the control
unmodified peptide. This observation suggests that H3R17me2a
and/or H3R26me2a may not exert effect in chromatin by serving
as docking sites for major chromatin associated proteins. A caveat
in our experiment is that we could not exclude the possibility that
the effectors for H3R17me2a and H3R26me2a (such as TDRD3)
might present in low abundance and thus were masked in gels by
other more abundant H3 peptide binding proteins.
Given the previous observation that H3R17me2a and
H3R26me2a is likely to function in conjunction with histone
acetylation [25,26], we therefore attempted to identify effector(s)
for these combinatorial codes. We instead find that H3R17me2a
and H3R26me2a, in conjunction with K9, K14, K18 and K23
Figure 4. Increased chromatin association of NuRD and TIF1b and decreased histone acetylation in Carm1 knockout MEF cells. (A)
Whole cell extracts were prepared from Carm1+/+ and Carm12/2 MEFs and subjected to Western blot analysis using antibodies as indicated. (B)
Chromatin fractions were prepared from Carm1+/+ and Carm12/2 MEFs and analyzed by Western blotting using antibodies as indicated. (C)
Western blot analysis of core histones prepared from the wild-type and Carm1 knockout MEFs by acid extraction.
doi:10.1371/journal.pone.0034692.g004
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NuRD and TIF1a and TIF1b to H3 tail (Fig. 1C). Although we
did not attempt to determine the protein identities for the
additional bands that bound to the acH3 but not ac/mRH3
peptide by mass spectrometry, Western blot analysis suggested that
they were primarily the components of NuRD complex including
HDAC1 and HDAC2. Based on our results and the previous
report that H3R2me2 inhibits the binding of several H3K4me2
effectors to H3 tail [16], we propose that arginine methylation in
histones is perhaps more likely to inhibit rather than recruit
effector proteins. Mechanistically, because arginine contains five
potential hydrogen bond donors that can form favorable in-
teraction with biological hydrogen bond acceptors, arginine
residues in histones are likely to widely engage in interaction with
histone binding proteins. Methylation on arginine not only
changes its shape but also affects the number of available
hydrogen bond donors, which in turn may inhibit the arginine-
engaged protein-protein interaction. Perhaps only for a small
group of tudor domain proteins including TDRD3, arginine
methylation facilitates protein-protein interaction through hydro-
Figure 5. Chromatin immunoprecipitation (ChIP) assay demonstrated that expression of CARM1 resulted in reduced chromatin
association of NuRD and TIF1b. (A) Expression of CARM1 facilitates transcriptional activation by AR. HeLa cells were transfected with 100 ng
pREP7-MMTV-Luc reporter, 20 ng pSG5-Flag-AR plus 0, 100 ng, 200 ng or 400 ng of pSG5-CARM1 and treated with or without 10 nM R1881
overnight. The relative luciferase activities were based on triplicates of two experiments. (B) Expression of CARM1 alone activates transcription from
pREP7-MMTV-Luc reporter. pREP7-MMTV-Luc reporter was cotransfected with an increasing amount of pSG5-Flag-CARM1 plasmid. The relative
luciferase activities from two independent experiments were shown. (C) ChIP analysis revealed that expression of CARM1 resulted in reduced
association of NuRD and TIF1b with chromatin. HeLa cells were transfected with pREP7-MMTV-Luc reporter alone or plus 300 ng pSG5-Flag-CARM1.
One day after transfection, the cells were collected and proceeded for ChIP analysis using antibodies as indicated. Left panel shows Western blot data
for expression of Flag-CARM1. Arrow marks a non-specific band. PCR reactions were performed using a pair of MMTV-LTR specific primers and the
products were revealed by agarose gel electrophoresis. (D) ChIP products in C) were analyzed by quantitative PCR.
doi:10.1371/journal.pone.0034692.g005
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tudor domain.
As NuRD and TIF1b are transcriptional corepressors broadly
involved in transcriptional repression [40–43], our finding
immediately provides a potential mechanism for transcriptional
activation mediated by CARM1-catalyzed histone arginine
methylation: dissociating corepressors NuRD and TIF1b from
chromatin. We therefore focused our effort on testing whether
CARM1 indeed regulates the association of NuRD and TIF1b
with chromatin in cells. Several lines of evidence support that
CARM1 regulates the association of NuRD and TIF1b with
chromatin in cells. First, we show that induced overexpression of
CARM1 in 293 T cells led to reduced association of NuRD with
chromatin (Fig. 2C). Second, knockdown of CARM1 in HeLa cells
resulted in increased association of NuRD and TIF1b with
chromatin (Fig. 3B). Third, we observed in Carm12/2 MEF cells
an increased association of NuRD and TIF1b with chromatin
(Fig. 4B and 4C). Fourth, by ChIP analysis of a chromatinized
episomal reporter (Fig. 5C and 5D) and an endogenous NF-kb
target gene (Fig. 6C and 6D), we show that CARM1 regulates the
association of NuRD with chromatin. Together these in vitro and
in vivo results provide compelling evidence that CARM1 regulates
the association of NuRD and possibly other corepressor proteins
such as TIF1b with chromatin.
Another important observation in this study is that knockdown
of CARM1 in HeLa cells and knockout of CARM1 in MEF cells
lead to histone hypoacetylation. To our knowledge, this is the first
report that CARM1 has a role in regulating global histone
acetylation. This finding is consistent with a role of CARM1 in
regulating chromatin association of the chromatin remodeling and
histone deacetylase complex NuRD and TIF1b in these cells,
although we cannot rule out the possibility that CARM1 may also
regulate histone acetylation by influencing the HAT activities such
as CBP/p300. It is noteworthy that overexpression of CARM1 did
not appear to affect histone acetylation in 293 T cells (Fig. 2C),
although it did lead to reduced association of NuRD with
chromatin. Similarly, overexpression of CARM1 did not result in
histone hyperacetylation in episomal reporter (Fig. 5C and 5D).
Thus, whereas increased chromatin association of NuRD complex
correlates a reduced histone acetylation, reduced chromatin
association of NuRD does not necessarily lead to a global increase
in histone acetylation, suggesting that the global levels of histone
acetylation are likely regulated by additional factors such as the
activity of other HDACs and/or limited activities of histone
acetyltransferases.
It is also noteworthy we observe in this study that acetylation on
K9, K14, K18 and K23 drastically reduces the binding of HeLa
nuclear proteins to H3 tail. This result is consistent with previous
reports [44] and suggests that many proteins bind to H3 tail
peptide through hydrophilic interactions with positive charged
lysine residues. Although a few proteins bound to the acH3
peptide as shown in Fig. 1B, these proteins does not appear to bind
specifically to acH3 peptide, because among them are TIF1a,
TIF1b and MTA1, which clearly bound more avidly to H3
peptide than to acH3 peptide (Fig. 1C and 1D).
Taking together, both our in vitro and in vivo data support
a working model in Fig. 6E. In this model, CARM1-mediated
H3R17me2a and H3R26me2a has a role in releasing corepressors
from chromatin in conjunction with histone acetylation. This
model is consistent with previous studies showing that CARM1
and its catalyzed H3R17/26 methylation facilitate transcriptional
activation subsequent to the step of histone acetylation [23,24].
Our study therefore adds a new flavor to the mechanisms by which
CARM1 regulates transcription: relief of repression by NuRD and
TIF1 family proteins. Our study also uncovers a role of CARM1
in protecting acetylated histones from deacetylation by NuRD
complex.
Materials and Methods
Plasmids, Antibody, Cell Lines, Transfection and
Stable Cell Line
The CARM1 expression plasmids pCMV-HA-CARM1 and
pcDNA5/FRT/TO-CARM1 were constructed by cloning the
full-length mouse CARM1 into pCMV-HA and pcDNA5/FRT/
TO vector. The ppyCAGIP-AR was constructed by inserting the
full-length AR amplified from pSG5-AR into the vector
ppyCAGIP. The pREP7-MMTV-luc episomal reporter was
constructed by replacing the original RSV-LTR with MMTV-
LTR-Luc from pMMTV-LTR-Luc reporter. All constructs were
verified by DNA sequencing.
The commercial antibodies used were H3, acH3, acH4,
H3R17me2a and TIF1b/KAP1 from Abcam (Cambridge, MA,
USA); HA from Roche Molecular Biochemicals; nucleolin and
MTA1 from eBioscience (San Diego, CA) and mouse monoclonal
CARM1 antibody from AbMart (Shanghai, China). Rabbit
polyclonal anti-HDAC1 antibody was a kind gift from Dr Jiangou
Song (Shanghai Institute of Biochemistry and Cell Biology,
Shanghai, China). Antibodies against CHD3 and CHD4 were
kindly provided by Dr. Weidong Wang (National Institute of
Aging, Baltimore, USA). Antibody against MTA2 was kindly
provided by Dr. Ping Zhu (The Institute of Biophysics, Chinese
Academy of Sciences, Beijing). NPM1 antibody was generated by
immunizing rabbits with GST-NPM1.
HeLa and 293 T cell lines were obtained from the American
Type Culture Collection (ATCC, Manassas, VA). The 293 T Flp-
In T-Rex cell line was obtained from Invitrogen Corporation
(Carlsbad, CA) and the CARM1(+/+) and CARM1(2/2) MEF
cell lines were kindly provided by Dr. Mark Bedford (MD
Anderson Cancer Center, Smithville, TX). HeLa, 293 T, 293 T
Flp-In T-Rex, CARM1(+/+) and CARM1(2/2) MEF cell lines
were maintained routinely in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum. Transient
transfections in 293 T and HeLa cells were performed using
lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions.
Figure 6. CARM1 regulates the chromatin association of NuRD with a NF-kb-dependent gene. (A) and (B) The Carm1(+/+) and Carm1(2/
2) MEF cells were treated with or without 10 mg/ml LPS for 4 h. The total RNAs were prepared and analyzed by quantitative RT-PCR for LPS induction
of NF-kb-regulated target genes MIP2 and GCSF respectively. (C) and (D) The ChIP analyses were performed for the MIP2 promoter using Carm1(+/+)
and Carm1(2/2) MEF cells treated with or without LPS for 4 h. Note that the association of NuRD complex was determined using antibodies against
MTA2 and CHD4 antibodies, as the antibodies against MTA1 and CHD3 used in Fig. 5 did not work well for ChIP with MEF cells. The percentage of
DNA immunoprecipitated with each antibody was calculated relative to the ChIP input DNA. Values are means6SD (standard deviation) derived from
three independent ChIP experiments (E) A working model illustrating how CARM1 facilitates dissociation of NuRD and TIF1b from chromatin. CARM1
catalyzes methylation on H3R17 and H3R26. These modifications in the context of acetylation discharge NuRD and TIF1b from chromatin, which in
turn protects histone acetylation and enhances transcriptional activation.
doi:10.1371/journal.pone.0034692.g006
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Biotinylated H3 Peptides, Mass Spectrometry and
Western Blot Analysis
Nuclear extracts were prepared from HeLa cells by the protocol
of Dignam et al [45]. Biotinylated histone tail peptides containing
methylated arginines or acetylated lysines were synthesized and
purified by Beijing Scilight Biotechnology Ltd. Co. Purification of
corresponding H3 peptide binding proteins from HeLa nuclear
extracts and mass spectrometry were carried out essentially as
described [29]. Western blot analysis was performed using various
antibodies as described [46].
Pull-down Assay with in Vitro Synthesized Proteins
Radiolabeled proteins were generated with the TNT coupled
reticulocyte lysate system (Promega). In vitro pull-down assays were
carried out by incubating the in vitro translated products with
different modified histone H3 peptides at 4uC for 2 h. After
extensive washing, the products were resolved by 10% SDS–
PAGE and the presence of proteins was revealed by autoradiog-
raphy.
Generation of the Flag-CARM1 Inducible Stable Cell Line
and Induction Flag-CARM1 Expression
An inducible stable Flag-CARM1 cell line was generated by
transfecting the 293 T Flp-In T-Rex cells with pcDNA5/FRT/
TO-Flag-CARM1 and pOG44 according to the manufacturer’s
instruction from Invitrogen. To induce expression of Flag-
CARM1 in this cell line, doxycycline was added to the medium
at a final concentration of 1 mg/ml. The cells were cultured for
additional 4–24 hours before harvested and analyzed for Flag-
CARM1 expression and cellular fractionation.
Preparation of Cytosol, Nuclear Extract and Chromatin
To fractionate cellular contents into cytosol, nuclear and
chromatin fractions, cultured cells were collected by centrifugation
and washed twice with ice-cold PBS. The pellets were resuspended
in 2 packed cell volume of solution A (20 mM Tris, pH 8.0,
150 mM NaCl, 1% NP-40, 1 mM DTT and protease inhibitors),
incubated on ice for 10 minutes and centrifuged at 4000 rpm for
5 min at 4uC. The supernatants were collected and designated as
cytosol fractions. The pellets were washed with solution A once
and the resuspended in 2 packed cell volume of solution B (20 mM
Tris, pH 8.0, 450 mM NaCl, 1% NP-40, 1 mM DTT and
protease inhibitors). After incubation on ice for 10 minutes, the
samples were centrifuged at 12000 rpm for 10 min at 4uC. The
resulting supernatants were collected and designated as nuclear
extracts. The pellets were washed once with solution A,
resuspended in 2 volume of 16SDS loading buffer and designated
as chromatin fractions. The samples were boiled before electro-
phoresis.
Acid Extraction of Histones
The preparation of core histones by acid extraction was
performed as described [47]. The histone preparations were
resolved by 18% SDS-PAGE followed by Western blot analysis.
Luciferase Reporter Assays and RT-PCR Analysis
Transfections for luciferase activity assay were performed in
24-well plates using lipofectamine 2000 (Invitrogen). 48 hours
after transcfection, luciferase activity in the cell lysates was
determined by using a commercial luciferase reporter assay
system (Promega, WI, USA). In experiments with AR, R1881
was added at a final concentration of 10 nM 8 h before cells
were harvested for luciferase activity assay. The luciferase activity
was normalized against the protein concentration. For analysis of
LPS-induced transcriptional activation of MIP-2 and G-CSF
genes in Carm1(+/+) and Carm1(2/2) MEF cells, the cells were
treated with 10 mg/ml LPS (Sigma) for 4 h before cells were
collected for quantitative RT-PCR analysis. The primers are as
follow: MIP-2 forward CCGCCCAGACAGAAGTCATAGC,
MIP-2 reverse CAGACAGCGAGGCACATCAGG, G-CSF for-
ward GCAGGCTCTATCGGGTATTTCC and G-CSF reverse
GCTGGAAGGCAGAAGTGAAGG.
Chromatin Immunoprecipitation Assay
For chromatin immunoprecipitation (ChIP) assay with 293 T
cells transiently transfected with the pREP7-MMTV-luciferase
reporter plus pCMV-HA-CARM1 or its vector control, the cells
were treated with 1% formaldehyde 48 h after transfection for 10
minutes at RT. The cells were then harvested and ChIP assays
were performed essentially as described [48]. The ChIP primer
sequences for MMTV-LTR are: TTTCCCCAAAAGTG-
CATTCCT and CCCTCCCTTTTCGTGAAAGACT. For
ChIP assay using Carm1(+/+) and Carm1(2/2) MEF cells, the
MEF cells were treated with 10 mg/ml LPS (Sigma) for 4 h before
cells were collected for ChIP analysis as above. The ChIP primers
for the MIP-2 promoter are GACCAC-
CAAGTCTCTGTTTCTTGA and TGTCATATCCTTC-
TACCCGACTTG.
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